Fate Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Fate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Fate Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Fate Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.9M | 1.5M | 1.26 |
| 2025-03-31 | $1.9M | 2.5M | 0.79 |
| 2024-12-31 | $4.1M | 2.5M | 1.65 |
| 2024-09-30 | $9.9M | 2.8M | 3.50 |
| 2024-06-30 | $7.7M | 2.3M | 3.28 |
| 2024-03-31 | $15M | 2.0M | 7.34 |
| 2023-12-31 | $2.2M | 591k | 3.74 |
| 2023-09-30 | $1.0M | 495k | 2.12 |
| 2023-06-30 | $5.2M | 1.1M | 4.76 |
| 2023-03-31 | $7.6M | 1.3M | 5.70 |
| 2022-12-31 | $8.2M | 810k | 10.09 |
| 2022-06-30 | $27M | 1.1M | 24.78 |
| 2022-03-31 | $8.8M | 227k | 38.77 |
| 2021-12-31 | $24M | 407k | 58.51 |
| 2021-09-30 | $34M | 571k | 59.27 |
| 2021-03-31 | $68M | 820k | 82.45 |
| 2020-12-31 | $71M | 775k | 90.93 |
| 2020-09-30 | $52M | 1.3M | 39.97 |
| 2020-06-30 | $36M | 1.0M | 34.31 |
| 2019-12-31 | $13M | 675k | 19.57 |
| 2019-09-30 | $7.1M | 457k | 15.53 |
| 2019-06-30 | $9.0M | 444k | 20.30 |
| 2019-03-31 | $6.7M | 379k | 17.57 |
| 2018-12-31 | $4.4M | 345k | 12.83 |
| 2018-09-30 | $1.6M | 100k | 16.28 |
| 2018-06-30 | $310k | 27k | 11.36 |
| 2017-12-31 | $311k | 51k | 6.10 |
| 2017-09-30 | $500k | 126k | 3.96 |
| 2017-06-30 | $362k | 112k | 3.24 |
| 2017-03-31 | $655k | 144k | 4.55 |
| 2016-12-31 | $62k | 25k | 2.49 |
| 2016-09-30 | $111k | 35k | 3.13 |
| 2016-06-30 | $61k | 36k | 1.70 |
| 2016-03-31 | $313k | 174k | 1.80 |
| 2015-12-31 | $90k | 27k | 3.37 |
| 2015-09-30 | $79k | 15k | 5.34 |
| 2015-06-30 | $79k | 12k | 6.45 |
| 2015-03-31 | $181k | 37k | 4.89 |
| 2014-12-31 | $369k | 73k | 5.02 |
| 2014-03-31 | $256k | 26k | 9.73 |
| 2013-12-31 | $257k | 41k | 6.27 |